Purchase Order 68HE0B23P0634
- Not listed
- This is a $19,153.30 firm fixed-price purchase order awarded to Cayman Chemical Co Inc., a manufacturer of biochemicals, assay kits, and other chemical products. The order is for the Drug Enforcement Administration and has a delivery date of April 30, 2024. Cayman Chemical has provided similar products and services to federal agencies like the CDC and Department of Defense in support of drug enforcement operations, forensic analysis, and substance abuse prevention efforts. The company has...
- This is a purchase order awarded by the Department of Justice Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products located in Ann Arbor, Michigan. The contract has a firm fixed price of $20,364.00 and a completion date of September 30, 2024. The contract is to provide the DEA with specialized reagents, test kits, and analytical standards to support the agency's work related to the opioid epidemic. Cayman Chemical is a well-established federal...
- This is a firm fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc. for $84,575.00. The contract is for the purchase of 17 substances for diversion and control purposes. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The contract has a total small business set-aside...
- Cayman Chemical Co Inc. has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at ten thousand seven hundred eighty-eight dollars and twenty cents ($10,788.20) by the Defense Health Agency. Under this contract, Cayman Chemical will provide standards to the agency for use in screening and confirmation of suspected drug use in service member and/or post-mortem urine, blood, and tissue samples. Performance will occur in Ann Arbor, Michigan and the contract is...
- This is a $27,350.00 firm fixed price purchase order awarded to Cayman Chemical Co Inc. by the Drug Enforcement Administration (DEA) on August 1, 2024. The contract is for the purchase of three substances to be used in testing, with a delivery date of December 20, 2024. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The company...
- This is a $38,450.00 firm fixed price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The purchase order is for 8 substances and has a completion date of June 27, 2024. Cayman Chemical is a major supplier of reference materials, analytical standards, and specialized reagents to federal agencies for drug enforcement, public health, and biomedical research. The company has...
- This is a firm-fixed price BPA call order awarded by the Defense Health Agency (DHA) to Cayman Chemical Co Inc., a leading manufacturer of biochemical products and research tools. The contract, valued at $11,540.48, is for the delivery of drug standards to be used for drug screening and evaluation testing of service member specimens. Cayman Chemical has an established track record of providing reference materials, analytical standards, and specialized reagents to support federal agencies' drug...
- This federal contract award was issued by the National Institute of Environmental Health Sciences, a civilian agency, to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The $10,003.50 firm-fixed-price purchase order is for the delivery of Cortisol EIA Kits, which are used in substance abuse testing and biomedical research. Cayman Chemical has a strong track record of supplying critical materials to government agencies, including the Drug Enforcement...
- This is a $24,069 firm-fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products and research tools. The contract supports the DEA's drug enforcement and analysis efforts by providing reference materials, analytical standards, and specialized reagents. Cayman Chemical has an established track record of supplying the DEA and other federal agencies, such as the Centers for Disease Control and Prevention...
- This is a contract awarded by the NIAID DEA OA Acquisitions division of the Department of Health and Human Services (HHS) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The contract is for the purchase of a PRECELLYS MINILYS-PERSONAL TISSUE HOMOGEIZER, catalog# 10435, with a ceiling value of $3,781.00. It is a firm fixed price purchase order with a completion date of February 18, 2012. The contract does not have a set-aside designation. Cayman...
This is a firm fixed-price purchase order contract awarded by the Office of Research and Development, a civilian U.S. government agency, to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools located in Ann Arbor, Michigan. The contract is for the delivery of ASSAY KITS with a total ceiling value of $11,914.20 and a period of performance ending on September 30, 2024. The contract was awarded on September 18, 2023 and is not set aside for small businesses. Cayman Chemical Co Inc. is a key supplier of reference materials, assay kits, and specialized reagents to federal agencies, particularly supporting drug enforcement, forensic analysis, public health, and biomedical research initiatives. The company has several existing federal contract vehicles, including a $1.5 million single-award blanket purchase agreement with the Defense Health Agency for chemicals and medical supplies, and a $130,000 blanket purchase agreement with the Department of the Army Medical Command for supplying chemicals to forensic drug testing laboratories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($36) | 8/19/25 | |
| Not listed | Not listed | $12.0k | 9/18/23 |